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OBJECTIVE — The associations of prenatal exposures to maternal prepregnancy overweight
and gestational diabetes mellitus (GDM) with offspring overweight are controversial. Research
estimatingriskforoffspringoverweightduetotheseexposures,separatelyandconcomitantly,is
limited.
RESEARCH DESIGN AND METHODS — Prevalence of overweight and abdominal
obesity at age 16 years and odds ratios (ORs) for prenatal exposures to maternal prepregnancy
overweight and GDM were estimated in participants of the prospective longitudinal Northern
Finland Birth Cohort of 1986 (N  4,168).
RESULTS — Theprevalenceandestimatesofriskforoverweightandabdominalobesitywere
highest in those exposed to both maternal prepregnancy overweight and GDM (overweight
prevalence 40% [OR 4.05], abdominal obesity prevalence 25.7% [3.82]). Even in offspring of
mothers with a normal oral glucose tolerance test during pregnancy, maternal prepregnancy
overweight is associated with increased risk for these outcomes (overweight prevalence 27.9%
[2.56], abdominal obesity prevalence 19.5% [2.60]). In offspring of women with prepregnancy
normal weight, the prevalence or risks of the outcomes were not increased by prenatal exposure
to GDM. These estimates of risk were adjusted for parental prepregnancy smoking, paternal
overweight, and offspring sex and size at birth.
CONCLUSIONS — Maternal prepregnancy overweight is an independent risk factor for
offspring overweight and abdominal obesity at age 16 years. The risks are highest in offspring
with concomitant prenatal exposure to maternal prepregnancy overweight and GDM, whereas
the risks associated with GDM are only small.
Diabetes Care 33:1115–1121, 2010
B
y 1961, Pedersen (1) had already
described the phenotype of the in-
fant with prenatal exposure to ma-
ternal diabetes as “Most conspicuous…,
the round cherub’s cheeks, buried eyes,
andshortneck.”Hesuggestedthatmater-
nal hyperglycemia leads to fetal hyperin-
sulinemia and increased growth, a
hypothesisthatisstillthebasisofresearch
on maternal-fetal metabolism. Increasing
evidence suggests that prenatal exposure
to a hyperglycemic environment can alter
growth trajectories and homeostatic reg-
ulatory mechanisms, thus causing life-
long changes that result in an increased
risk of overweight and obesity (2–5).
However, in several studies the associa-
tion of prenatal exposure to gestational
diabetes mellitus (GDM) with overweight
laterinlifehasbeenattenuatedwhencon-
trolling for maternal weight (6–10).
We have previously observed adoles-
cent offspring of mothers with GDM to
haveahigherBMIthanoffspringofmoth-
ers with no risk factors for GDM (11). In
the present study, we estimated the risks
of overweight and abdominal obesity at
age 16 years associated with prenatal ex-
posures to maternal prepregnancy over-
weight and GDM, separately and
concomitantly, based on the prospective
Northern Finland Birth Cohort of 1986
(NFBC 1986).
RESEARCH DESIGN AND
METHODS
Maternal health care, screening and
diagnosing GDM during the study
period
In Finland, cost-free health care is offered
to all pregnant women at maternity wel-
fare clinics (MWCs). Practically all preg-
nant women attend these clinics. During
the study period, GDM screening and di-
agnosisintheMWCswasbasedonassess-
ment of risk factors, in accordance with
national guidelines. The women were
considered to be at risk for GDM if one or
more of the following risk factors were
present:ageover40years,BMI25kg/m
2,
prior GDM, previous delivery of a macro-
somic infant (birth weight 4,500 g),
glucosuria, and suspected fetal macroso-
mia in the current pregnancy. These
womenunderwentglucosetolerancetest-
ing, performed after an overnight fast,
conducted by administering a 2-h, 75-g
oral glucose tolerance test (OGTT). The
upper ranges of normal capillary blood
glucose concentrations in 1985–1986
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and at 1 h and 2 h after the glucose load,
respectively. Importantly, diagnosis of
GDM was set after one abnormal value in
the OGTT, according to prevailing na-
tional guidelines.
The women with diagnosed GDM re-
ceiveddietaryadviceandmonitoredtheir
blood glucose values at home, reporting
them weekly to the delivery diabetes
nurse at the delivery hospital. If fasting
plasmaglucoseconcentrationsrepeatedly
exceeded 5.3 mmol/l or 2-h postprandial
concentrations exceeded 6.7 mmol/l, gu-
argum or insulin therapy was initiated.
Study population and data
collection
We used data based on participants of the
NFBC 1986 (n  9,362 mothers and fa-
thers and 9,479 offspring) who were re-
cruited and longitudinally assessed as
described previously (11,12). Brieﬂy,
births to women with an expected deliv-
ery date between 1 July 1985 and 30 June
1986 in the two northernmost provinces
of Finland were eligible. Data on parents
and children were acquired prospec-
tively, starting in the 12th gestational
week, and were collected antenatally, at
birth, and at the ages of 7 and 16 years.
The latest follow-up, occurring in 2001–
2002 at offspring age 16 years, consisted
ofquestionnairesforparentsandchildren
(participation rate 80%) and a clinical ex-
amination of the children (participation
rate74%)forthoseparticipantswhowere
alive and traceable. In the present study,
we excluded children born from multiple
gestations (n  229), of parents with di-
abetes diagnosed before pregnancy (n 
73), and of mothers with risk factors for
GDMbut without an OGTT performed in
pregnancy (n  1,942) and those who
had not participated in the clinical fol-
low-up examination or had incomplete
data on the outcome variables (n 
3,020). The study population included
4,168 adolescents, 2,092 males and
2,076 females (Fig. 1). Adolescents and
parents received written and oral infor-
mation and gave their written informed
consent. The Ethics Committee of North-
ern Osthrobothnia Hospital District ap-
proved the study.
Trained nurses helped mothers ﬁll in
twoquestionnairesatMWCs.Theseques-
tionnaires covered the early (data since
12th–16th gestational week) and late
pregnancy(after24weeksofgestationin-
cluding the perinatal period). A third
questionnaire was ﬁlled in at the hospital
by the attending midwives, who also re-
cordedgestationalage,weight,andlength
at birth. The course of pregnancy and de-
livery, including complications and dis-
eases,werefurtherconﬁrmedfromMWC
and hospital patient records, as was the
neonatal outcome. In 2000–2001 the
parents and children ﬁlled in detailed
postalquestionnaires.Atage16years,the
adolescents attended a clinical examina-
Figure 1—Flow chart of the NFBC 1986 study population.
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surements taken included, among others,
height, weight, and waist circumference
at the level midway between the lowest
rib margin and the iliac crest.
Data on maternal prepregnancy over-
weight,susceptibilitytoGDM,andOGTT
results in pregnancy were used to create
an exposure variable as follows: Mater-
nal prepregnancy BMIs were calculat-
ed and classiﬁed as normal weight/
overweight with a cut off at 25 kg/m
2.
The mothers were classiﬁed according to
their predisposition to GDM and OGTT
results in pregnancy (no risk factors for
GDM, risk factor/s for GDM but diagnos-
tic OGTT normal, and GDM). Thereafter,
a ﬁve-class variable was created: prenatal
exposure to overweight and GDM (1),
GDM only (2), overweight and maternal
risk factors for GDM (3), maternal risk
factors for GDM only (4), and no risk fac-
tors for GDM (5) (Fig. 1).
Possible confounding and interven-
ing variables were treated as follows: Sex,
socioeconomic status, prenatal exposure
to maternal and paternal smoking, and
paternal prepregnancy overweight were
considered confounding factors. Off-
spring size at birth was considered an in-
tervening factor. Duration of maternal
education was used as a measure for
socioeconomic status and classiﬁed as
low/highwithacutoffat9years.Prepreg-
nancy smoking was classiﬁed as smoker
and nonsmoker for both parents. Fathers’
BMIs in 1985–1986 were calculated and
classiﬁed as for mothers in prepregnancy.
Offspring size at birth was classiﬁed as
appropriateforgestationalage(AGA)and
small (SGA) and large (LGA) for gesta-
tionalageaccordingto2SDsofthesex–
and gestational age–speciﬁc cohort
distributions.
The outcomes considered were 1)
overweight including obesity and 2) ab-
dominal obesity of the offspring at age 16
years. Overweight including obesity was
deﬁned according to the International
Obesity Task Force age- and sex-speciﬁc
criteria(13).Theratioofwaisttoheightis
a measure of central fatness that has
emerged as a signiﬁcant predictor of car-
diovascular disease in children and ado-
lescents (14). In the present study,
abdominal obesity was deﬁned as waist-
to-height ratio 0.5.
Statistical methods
Statistical analyses were performed using
SPSS version 15.0 (SPSS, Chicago, Illi-
nois). The distributions of variables for
clinical characteristics were skewed and
therefore logarithmically transformed.
These data are presented as geometric
means and 95% conﬁdence intervals
(CIs). ANOVA was used for comparisons
of variables between groups. Categorical
data are presented as percentages. Pear-
son’s 
2 test was used to evaluate differ-
ences between groups for categorized
variables.
Logistic regression analysis was used
to evaluate the independent associations
of prenatal exposures with outcome vari-
ables. To create the adjusted regression
models,prenatalexposureandconfound-
ing/intervening variables with a statisti-
cally signiﬁcant odds ratio (OR) in the
unadjusted analyses were entered simul-
taneously. All two-way interactions be-
tween predictors were tested for and
found to be nonsigniﬁcant (data not
shown).
In data attrition analysis, there were
no statistically signiﬁcant differences be-
tween the study population and the over-
all cohort in maternal age, child birth
weight, or birth length. The mothers and
fathers in the study population had a
lower BMI at the initiation of the study
compared with the overall cohort (geo-
metric means of mothers’ BMI 21.3 vs.
22.1 kg/m
2, P  0.001; fathers’ BMI 23.8
vs. 23.9 kg/m
2, P  0.005).
RESULTS
Prenatal and birth data
The prevalence of GDM was 2.0%. Insu-
lin therapy was initiated in 9.5% of the
mothers with GDM. Mothers with GDM
were more often overweight before preg-
nancy than mothers with a normal OGTT
(41.7vs.23.6%,respectively).Themater-
nal, paternal, and newborn characteris-
tics, assorted according to maternal
glucose metabolism in pregnancy and
overweight, are shown in Table 1.
Outcome variables
At age 16 years, 12.7% of the offspring in
the whole cohort were overweight, and
8.3% had abdominal obesity. In offspring
of mothers with prepregnancy normal
weight, the prevalences of these outcome
variables were similar irrespective of ma-
ternal glucose metabolism in pregnancy.
In offspring of mothers with prepreg-
nancy overweight, the prevalences of the
outcome variables were increased, espe-
cially when prenatal exposure to GDM
was also present (Fig. 2).
Estimates of risk
In unadjusted analyses, the risks for the
outcomes were greatest in offspring with
prenatal exposures to both GDM and ma-
ternal overweight (overweight OR 4.05,
abdominal obesity 3.82). Prenatal expo-
sure to maternal overweight associated
with increased risk of overweight (OR
2.56) and abdominal obesity (2.60), even
in offspring of mothers with a normal
OGTT during pregnancy. In offspring of
normalweightwomen,prenatalexposure
to maternal GDM was not associated with
increased risks of the outcome measures.
These associations remained even after
adjustment for confounding/intervening
factors (Table 2).
In unadjusted analyses of the con-
founding/intervening variables, prenatal
exposures to paternal overweight, mater-
nal and paternal smoking, male sex, and
being born LGA were associated with in-
creased risks of both outcome measures.
In adjusted analyses, the associations re-
mained for prenatal exposures to mater-
nal smoking and paternal overweight for
bothoutcomemeasures(Table2).Thees-
timates of risk did not differ between
sexes, except for the association of prena-
talexposuretosmokingwiththeoutcome
measures,whichwasfoundonlyinsame-
sex parent-child pairs (data not shown).
CONCLUSIONS — Our study pre-
sents estimates of risk of overweight and
abdominal obesity for prenatal exposures
tomaternalprepregnancyoverweightand
GDM separately. Maternal overweight
emerged as an essential risk factor for
both outcomes. The risks associated with
concomitant exposure to maternal
prepregnancy overweight and GDM were
high. In offspring of normal-weight
women, no statistically signiﬁcant risks
for overweight and abdominal obesity
were associated with prenatal exposure
to GDM.
Previousstudiesassessingoverweight
after prenatal exposure to GDM have not
always controlled for maternal over-
weight. The studies that have controlled
for maternal overweight are conﬂicting.
Four studies have found an independent
association between prenatal exposure to
maternal GDM and offspring overweight
(14–17). The results from the Pima In-
dianStudy(14)maynotbegeneralizedto
other populations, and two other studies
were retrospective and lacked a control
group of mothers with normal glucose
tolerance (16,17). Four retrospective
studieshavefoundthatprenatalexposure
Pirkola and Associates
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ated with offspring obesity (6–9); one
lacked a control group of mothers with
normalglucosetolerance(8),andonewas
questionnaire-based (9). A recent study
by Catalano et al. (10) suggests that ma-
ternal prepregnancy overweight is the
strongest predictor of childhood obesity,
independent of maternal glucose metab-
olismduringpregnancyoroffspringbirth
weight. Our results support this; in addi-
tion, we found that prenatal exposure to
prepregnancy overweight combined with
GDM conveys an even higher risk for off-
springoverweightthanprenatalexposure
to maternal prepregnancy overweight
alone.
It has been suggested that the theory
of fuel-mediated teratogenesis might be
expanded to include fetal overnutrition
due to maternal obesity in pregnancy
(18). To test the fetal overnutrition hy-
pothesis, the effect of maternal and pater-
nal prepregnancy BMI on later offspring
BMI should be compared (19). Some pre-
vious studies have found support for the
hypothesis (19,20), while others have
challenged it (21–23). In the present
study, a greater fraction of the risk for
overweight and abdominal obesity at age
16yearswasattributabletomaternalthan
paternal overweight during the fetal pe-
riod of the offspring. Thus, our results
support the fetal overnutrition hypothe-
sis. However, this must be treated with
caution, as maternal prepregnancy over-
weight may inﬂuence offspring over-
weight not only via the intrauterine milieu,
but also via genetic and/or postnatal envi-
ronment and lifestyle factors, which are be-
yond the scope of the present study.
A recent meta-analysis has estimated
the OR of exposure to maternal smoking
for obesity between the ages of 3 and 33
years to be 1.50 (24), but to our knowl-
edge there are no previous studies that
haveassessedtheeffectsofprenatalexpo-
sure to GDM, parental overweight, and
smoking simultaneously. In addition to
conﬁrming the association of maternal
smoking with offspring overweight, even
when adjusting for several factors, we ob-
served that prenatal exposure to paternal
smoking was associated with increased
risk of abdominal obesity in offspring.
The association of intrauterine exposure
to smoking with the outcome measures
was stronger in same-sex parent-child
pairs; we speculate this may be due to an
additional lifestyle effect, assuming that
smoking may associate with an obesity-
pronelifestyleadoptedfromthesame-sex
parent.
The screening and diagnosis of GDM
is a subject of debate (2). In the present
study, the screening for GDM was risk-
factor based; the cut offs for the OGTT
results in pregnancy differed from those
recommended by the American Diabetes
Association (25), and the diagnosis of
GDM was made after one abnormal value
in the 75-g OGTT. Thus, some women
Table1—Characteristicsofmothers,fathers,andchildrenintheNFBC1986assortedaccordingtomaternalprepregnancyweightandglucose
metabolism in pregnancy
Maternal glucose metabolism and weight
GDM OGTT normal Control P*
Overweight Normal weight Overweight Normal weight
n† 30–35 42–49 136–154 439–503 2,837–3,427
Mothers
Age (years) 34.8 (32.8–36.9) 27.4 (25.8–29.1) 29.4 (28.5–30.3) 27.2 (26.8–27.7) 26.9 (26.7–27.0) 0.001
Height (m) 1.62 (1.60–1.64) 1.63 (1.61–1.65) 1.63 (1.62–1.64) 1.64 (1.63–1.64) 1.63 (1.63–1.63) NS
Weight (kg) 75.9 (72.9–79.1) 56.4 (54.5–58.4) 76.8 (75.1–78.5) 57.1 (56.5–57.6) 56.0 (55.8–56.2) 0.001
Prepregnancy BMI (kg/m
2) 29.0 (28.1–29.9) 21.2 (20.7–21.8) 28.9 (28.4–29.5) 21.3 (21.1–21.5) 21.0 (20.9–21.1) 0.001
% Nulliparous 9.1 41.3 24.0 37.2 36.6 0.001
% Smoker 11.4 14.6 14.6 14.3 18.3 NS
% Education 9 years 20.0 2.2 9.3 5.1 4.4 0.001
Fathers
Height (m) 1.77 (1.74–1.79) 1.78 (1.76–1.80) 1.76 (1.75–1.78) 1.77 (1.76–1.78) 1.77 (1.77–1.77) NS
Weight (kg) 83.0 (77.8–88.5) 76.4 (73.0–80.0) 75.3 (73.5–77.0) 74.6 (73.8–75.5) 73.9 (73.6–74.2) 0.001
BMI (kg/m
2) 26.7 (25.3–28.1) 24.3 (23.4–25.1) 24.2 (23.8–24.6) 23.8 (23.6–24.1) 23.7 (23.6–23.8) 0.001
% Overweight 56.7 38.1 36.0 32.0 28.3 0.001
% Smoker 31.3 42.9 38.4 35.8 37.8 NS
Children
Newborn
Gestational age (weeks) 38.5 (37.8–39.1) 39.0 (38.6–39.5) 39.4 (39.1–39.6) 39.5 (39.4–39.7) 39.5 (39.4–39.5) 0.001
Weight (kg) 3.70 (3.49–3.92) 3.67 (3.53–3.82) 3.78 (3.68–3.88) 3.69 (3.64–3.74) 3.48 (3.46–3.50) 0.001
% Male 60.0 55.1 55.8 52.1 49.5 NS
% SGA 0 0 1.9 0.6 2.2 NS
% LGA 8.6 2.0 10.4 6.2 0.4 0.001
Age 16 years
Height (m) 1.72 (1.69–1.74) 1.71 (1.69–1.74) 1.71 (1.69–1.72) 1.70 (1.69–1.71) 1.69 (1.69–1.69) 0.001
Weight (kg) 66.7 (61.9–72.0) 61.6 (58.6–64.8) 65.2 (63.1–67.4) 59.8 (58.9–60.8) 58.9 (58.6–59.2) 0.001
BMI (kg/m
2) 22.7 (21.3–24.1) 21.0 (20.5–21.5) 22.4 (21.8–23.1) 20.7 (20.5–21.0) 20.7 (20.6–20.8) 0.001
Waist (cm) 77.4 (73.1–82.0) 74.6 (72.1–77.3) 77.4 (75.7–79.2) 72.9 (72.3–73.6) 72.6 (72.4–72.9) 0.001
Data are geometric means (95% CI) for continuous variables and percentage for categorical variables. *P value for difference between groups from ANOVA for
continuous variables and 
2 test for categorical variables. †n varies due to incomplete data, most often missing paternal BMI. NS, not signiﬁcant.
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disease may have gone undetected, and
women with relatively mild disturbances
in glucose metabolism are included in the
GDM group. However, as we observed
that prenatal exposure to GDM increased
the risks for the outcome measures in
offspring of overweight mothers quite
strikingly, it seems that even mild distur-
bances in maternal glucose metabolism
are a risk factor for offspring overweight
and abdominal obesity.
Maternal hyperglycemia, irrespective
ofitsetiology,hasbeenpostulatedtohave
similar long-term effects on the offspring
(15). However, the genetic factors con-
tributing to the predisposition to meta-
bolic disturbances in offspring and the
timing of prenatal exposure to hypergly-
cemia are not identical in offspring of
motherswithtype1,type2,andGDM.As
Figure2—Prevalence(%)ofoverweightandabdominalobesityinoffspringoftheNFBC1986atage16years.Dataassortedaccordingtomaternal
glucose metabolism in pregnancy and prepregnancy BMI.  , Offspring of normal weight mothers; f, offspring of overweight mothers. (Note
difference in scale on y-axis.)
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quencesofprenatalexposurestodifferent
diabetes types in humans is limited, the
results of this study are comparable only
with studies on prenatal exposure to
GDM.
To date, the NFBC 1986 is one of the
most comprehensive, prospective, long-
term follow-up cohort of offspring ex-
posedtoGDMinageneralpopulation.All
participants were white Caucasian, born
in the same area during the same time
period, and similarly followed-up at the
same age. The virtually 100% coverage of
antenatal care in the MWCs enabled ex-
tensive, prospective data collection. The
exceptionally high retention rate further
addstothevalueofthisstudy.Inaddition
to distinguishing between the effects of
GDM and maternal overweight, the
present study accounted for several con-
founding factors, even paternal variables.
Despite the large number of participants
in the NFBC 1986, the number in the
stratiﬁedanalysesdidnotallowstablerisk
estimates for very many predictors. Thus,
to avoid overparameterization, we chose
to concentrate on prenatal factors as de-
terminants of later overweight and ab-
dominal obesity. Even though the study
groups were quite small, the differences
observed were statistically signiﬁcant and
clinicallyplausible,andwethereforecon-
sider the results highly relevant.
In summary, we present novel, pro-
spective data on the risks of overweight
and abdominal obesity associated with
prenatal exposures to maternal prepreg-
nancy overweight and GDM. Prenatal
exposure to maternal prepregnancy
overweight was an independent risk fac-
tor for both outcomes. The risks of over-
weight and abdominal obesity associated
with concomitant prenatal exposures to
maternal prepregnancy overweight and
GDM were alarmingly high. Given the
well-known health risks related to over-
weight and abdominal obesity and the
rising prevalence of both maternal
prepregnancy overweight and GDM, the
resultsofthepresentstudywarrantpublic
health attention.
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Table2—Estimatesofriskforoverweightandabdominalobesityinoffspringatage16yearsforprenatalexposuresandpossibleconfounding/
intervening factors
Overweight Abdominal obesity
Risk factors Unadjusted OR Adjusted OR† Unadjusted OR Adjusted OR†
Maternal
Glucose metabolism in
pregnancy and
prepregnancy weight
Control 1 (ref.) 1 (ref.) 1 (ref.) 1 (ref.)
OGTT normal
Normal weight 1.18 0.90, 1.56 1.13 0.83, 1.54 1.23 0.89, 1.72 1.16 0.80, 1.67
Overweight 2.92** 2.03, 4.22 2.56** 1.69, 3.88 2.97** 1.95, 4.51 2.60** 1.62, 4.17
GDM
Normal weight 0.67 0.24, 1.89 0.73 0.26, 2.08 1.09 0.39, 3.06 1.22 0.43, 3.48
Overweight 5.03** 2.54, 9.97 4.05** 1.90, 8.62 4.25** 1.97, 9.16 3.82* 1.66, 8.82
Smoking
No 1 (ref.) 1 (ref.) 1 (ref.) 1 (ref.)
Yes 1.39* 1.11, 1.74 1.31* 1.00, 1.71 1.54* 1.18, 2.00 1.42* 1.04, 1.93
Education
High 1 (ref.) 1 (ref.)
Low 1.41 0.93, 2.12 NA 1.41 0.86, 2.30 NA
Paternal
Overweight
No 1 (ref.) 1 (ref.) 1 (ref.) 1 (ref.)
Yes 2.19** 1.79, 2.68 2.14** 1.74, 2.63 2.11** 1.66, 2.68 2.02** 1.58, 2.59
Smoking
No 1 (ref.) 1 (ref.) 1 (ref.) 1 (ref.)
Yes 1.26* 1.04, 1.53 1.20 0.97, 1.49 1.41* 1.12, 1.78 1.36* 1.05, 1.76
Offspring sex
Female 1 (ref.) 1 (ref.) 1 (ref.)
Male 1.37* 1.14, 1.64 1.32* 1.07, 1.62 0.94 0.75, 1.17 NA
Birth size
AGA 1 (ref.) 1 (ref.) 1 (ref.)
SGA 0.65 0.30, 1.43 NA 1.06 0.48, 2.31 NA
LGA 1.99* 1.09, 3.63 1.28 0.62, 2.61 2.11* 1.06, 4.18 1.39 0.62, 3.09
*P  0.05, **P  0.001, †adjusted for factors with a statistically signiﬁcant OR in the unadjusted analyses.
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